Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples